Market news

Detailed price information for Neuronetics Inc (STIM-Q) from The Globe and Mail including charting and trades.

Detailed price information for Neuronetics Inc (STIM-Q) from The Globe and Mail including charting and trades.

Detailed price information for Neuronetics Inc (STIM-Q) from The Globe and Mail including charting and trades.

Moby summary of Neuronetics, Inc.'s Q2 2026 earnings call

Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regular session. The market value of their outstanding shares is at $151.0 million. As per the press release, Q2 earnings

Motley Fool Press Release.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Neuronetics (NASDAQ:STIM) reported second-quarter 2026 revenue growth, a sharply narrower net loss and positive adjusted EBITDA as its Greenbrook clinic business expanded and the company introduced additional commercial purchasing options for its NeuroStar transcranial magnetic stimulation, or TMS,

MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”), a leader in interventional mental...

BTIG initiates coverage on Neuronetics (STIM) with a Buy rating and $5 target as shares surge 28%. Read the details here.

Neuronetics, Inc. (NASDAQ:STIM) is one of the 10 High Growth Stocks Insiders Are Buying. On July 6, 2026, Neuronetics, Inc. (NASDAQ:STIM) announced that management will participate at B. Riley Securities’ Mind, Muscle & Vision Summit, an invitation-only institutional investor event being held in person at the InterContinental Boston. Neuronetics will participate in a panel discussion titled […]